Stockreport

Chimerix Reports First Quarter 2024 Financial Results and Provides Operational Update

Chimerix, Inc.  (CMRX) 
Last chimerix, inc. earnings: 2/25 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.chimerix.com/investor-relations
PDF – Dordaviprone (ONC201) ACTION Study Progressing; Reiterates Expectations for Interim Overall Survival (OS) Data in 2025 and Final OS Data in 2026 – – No Dose Limiting [Read more]